Business Context and Reporting Period
This Form 8-K, dated May 12, 2026, reports on GP-Act III Acquisition Corp., a Cayman Islands exempted company and emerging growth company. The filing details the entry into material definitive agreements on May 11, 2026, regarding an upcoming extraordinary general meeting of shareholders.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. As a special purpose acquisition company (SPAC) in the pre-business combination phase, the primary financial focus is the trust account established for the initial public offering. The filing notes that the Non-Redemption Agreements are expected to increase the amount of funds remaining in the trust account following the shareholder meeting.
Material Changes and Agreements
On May 11, 2026, the Company and its sponsor, GP-Act III Sponsor LLC, entered into Non-Redemption Agreements with investors holding an aggregate of 8,074,387 Class A ordinary shares. Key terms include:
- Shareholder Commitments: Investors agreed not to redeem their shares and to vote in favor of the Extension Amendment Proposal and Trust Amendment Proposal.
- Sponsor Consideration: In exchange, the Sponsor agreed to transfer 403,720 Class A ordinary shares to these investors following the closing of the initial business combination.
- Extension Proposals: The agreements support proposals to extend the deadline to consummate a business combination and liquidate the trust account from May 13, 2026, to November 13, 2026.
Outlook, Risks, and Management Commentary
Management intends to hold an extraordinary general meeting to vote on extending the company's operational timeline. The Non-Redemption Agreements are designed to increase the likelihood of shareholder approval for these extensions and preserve trust account liquidity.
Risks and Contingencies:
- The agreements terminate if shareholders fail to approve the extension proposals, if the company liquidates, or if an investor exercises redemption rights.
- Forward-looking statements regarding the approval of proposals and the amount of funds remaining in the trust are subject to significant risks, including market conditions and the inability to complete a business combination.
Investor Verification Checklist
- Verify the final vote count for the Extension Amendment Proposal and Trust Amendment Proposal at the extraordinary general meeting.
- Confirm the total number of shares redeemed versus the 8,074,387 shares covered by the Non-Redemption Agreements.
- Review the Definitive Proxy Statement (filed March 30, 2026) for detailed risk factors and participant information.
- Monitor the status of the 403,720 Class A ordinary shares to be transferred by the Sponsor upon closing of a business combination.